Manipal Health Enterprises IPO: Today’s GMP and Kostak Price Insights Revealed!

Manipal Health Enterprises Limited, incorporated in 2010, is set to debut on the Indian stock market with its Initial Public Offering (IPO). The company is a prominent healthcare service provider linked to the well-regarded Manipal Group, and as of March 31, 2026, it operates a vast network of 49 multi-specialty hospitals with over 13,000 licensed beds spread across 14 states and union territories. The organization offers a diverse range of medical services, including advanced care in organ transplants, oncology, and cardiology, supported by cutting-edge medical technology and a dedicated team of professionals. The IPO will likely generate interest among investors given the expanding healthcare sector in India.

In the grey market, sentiment indicates a cautiously optimistic outlook for Manipal Health’s IPO. Early trading has suggested a favorable markup, reflecting investor confidence in the company’s growth potential and the overall thriving sector. This market activity suggests that investors are anticipating a successful listing, driven by Manipal’s strong operational footprint and strategic growth initiatives in healthcare services.

For Indian investors, the listing of Manipal Health Enterprises Limited represents an opportunity to engage with a well-established player in the burgeoning healthcare market. As the demand for healthcare services continues to rise in India, particularly in a post-pandemic world, investing in this IPO could be a strategic move for those looking to capitalize on the long-term growth in the sector. Furthermore, with the company’s commitment to quality and patient-centric care, investors may find this an appealing addition to their portfolios amidst increasing emphasis on health and wellness.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)